26:18

Chemsex, já ouviu falar? - Respire / É de lei

30:47

Métodos de avaliação do sistema imune: Aspectos moleculares - Juliana Zanatta

23:38

Métodos de avaliação do sistema imune: Aspectos celulares - Andrea Niquirilo

01:17:58

Ciclo replicativo do HIV - Lúcio Gama

46:53

Vaccine efficacy using a recombinant herpesvirus with near-full-length SIV genome-Ronald Desrosiers

53:27

HIV and aging: role of the microbiome - Alan Landay

50:52

Inflammatory defenses are not for the faint of HAART - Michael Lederman

49:29

B cell analyses in HIV clinical trials: do you have to kiss a lot of frogs? - Adrian McDermott

57:55

HIV cure: challenges and solutions - Rafick Sekaly

45:41

HIV-1 Env glycoprotein trimers as a vaccine candidates - John Moore

38:10

Conventional HIV vaccines: any hope? - David Watkins

48:45

Using antibodies against HIV - Rebecca Lynch

44:45

When to start: revisiting START, same-day initiation, and TasP - Mauro Schechter

30:04

Discovery of neutralizing monoclonal antibodies against infectious diseases - David Matkins

44:39

STING controlled innmate immunity in HIV infectious disease, inflammation and cancer - Glen Barber

01:01:12

Development of vaccines for emerging infectious diseases - Barney Graham

55:15

Effect of Rapid ART initiation on HIV reservoir composition in HIV1 infected neonates-Dan Kuritzkies

36:46

How to present a poster and write a manuscript - Douglas Nixon

02:50

Chamada CAPHIV 2020.

53:04

Strategies to cure HIV infection - Mario Stevenson

01:00:22

Tratamento do HIV e resistência - Luiz Zanella

59:06

História natural da infecção pelo HIV - Ricardo Vasconselos

49:42

Revisão geral do sistema imune em doenças infecciosas - Esper Kallas

08:28

Abertura - Esper Kallas, Tarcisio Barros Filho

48:58

Experiências vividas na epidemia - Drauzio Varella

46:35

MHC class I antigen presentation in viral host defense - Ken Rock

55:02

Situação atual da epidemia de HIV/Aids no Brasil - Gerson Pereira

53:21

OL-10 controls immynity to vaccines and infections - Mario Stevenson

33:35

Traffic and how to beat it - Michael Lederman

51:28

Can CD8+ T-cells or natural killer cells be harnessed to eliminate persistent HIV reservoirs?

56:45

IL 10 Contributes to HIV persistence by promoting survival of latently infected cells - Rafick P

52:41

HIV erradication without reactivation - Susana Valente

36:22

Can the immune system be trained to eliminate HIV - Douglas Nixon

57:14

Targeting inflammation and viral persistence in nohuman primate models of HIV infection - Mirko

46:54

Inflammaging and HIV: A Dangerous Liasion - Alan Landay

55:48

AAV delivery of monoclonal Antibodies - Ronald Desrosiers

34:16

HIV Vaccines and antibody-based prevention - John Mascola

01:07:11

Situação Atual da Resposta Brasileira à epidemia de HIV AIDS - Adele Benzaken

21:37

Mesa Redonda: Cura do HIV

50:20

Imaging SIV transmission and prevention - Thomas Hope

44:10

Broadly neutralizing antibodies to HIV for prevention and therapy - Richard Koup

47:22

Investigating comorbid complications in people living with HIV on effective ART - Lishomwa Ndhlo

40:38

The Role of CD8+ T-cells and antibodies in the containment of SIV replication - David Watkins

46:18

Antigen presentation of viral antigens on MHC Class I molecules - Kenneth Rock

53:20

The case for persistent replication of HIV while taking ART - Timothy Schaker

01:03:04

Innate control of infections: The role of sting - Glen Barber

10:57

Abertura do Curso - José Otávio Auler, Adele Benzaken e Esper Kallás

42:32

Efficacy of CD8+ T-cells targeting HIV antigens - Tetsuro Matano

50:59

Tratamento da infecção pelo HIV - Ricardo Diaz

29:17

Mechanisms to erradicate HIV infected latent cells - Boris Matija Peterlin

53:26

Progress towards an HIV cure - Daniel Kuritzkies

41:54

Unravelling the B cell response to HIV germline targeting Immunogens, one cell at a time... - Adrian

47:23

Immunotherapy and an HIV remission - Steven Deeks

46:50

Using Antibodies to treat HIV-1 Infection - Rebecca Lynch

32:52

Tratamento da Infecção pelo HIV: quão eficaz é a supressão viral? - Ricardo Diaz

44:24

Mucin-antibody interactions can enhance HIV - Tom Hope

01:01:24

Situação atual da resposta Brasileira à epidemia de HIV/Aids - Adele Schwartz Benzaken

56:30

Novel vaccines to prevent tuberculosis - Thomas Evans

30:44

Sessão Controvérsias: Meu parceiro é indetectável , devo usar camisinha?

40:17

O impacto da PrEP na prevenção - Esper Kallas